Taipei, July 17, 2025 ––ImmunAdd Inc. is pleased to announce its participation in BIO Asia–Taiwan 2025, taking place from July 24 to July 27 at TaiNEX 2 (Taipei Nangang Exhibition Center Hall 2). During the exhibition, ImmunAdd will present key achievements from its next-generation vaccine adjuvant platform and engage with domestic and international partners across […]
Taipei, June 13, 2025 —ImmunAdd Inc., a Taiwan-based biotech company, announced its participation in the 2025 BIO International Convention, taking place June 16–19 at the Boston Convention and Exhibition Center. The company will present its latest advancements in synthetic vaccine adjuvants and immune modulation technologies to the global biotech community. At this year’s convention, ImmunAdd […]
TAIPEI, Taiwan May 15, 2025 – Japan Patent Office has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan May 12, 2025 – U.S. Patent and Trademark Office has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan Mar. 5, 2025 – Korean Intellectual Property Office has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan Oct. 23, 2024 – The Israel Patent Office has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan Oct. 23, 2024 – China National Intellectual Property Administration has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan Jul. 10, 2024 – ImmunAdd won the Startup of the Year at the 2024 Taiwan BIO Awards and the Awards ceremony will be held on July 25th. ImmunAdd is a biotech pharmaceutical research and development company focused on drug design and formulation development. ImmunAdd was founded in 2022 but has put efforts into […]
TAIPEI, Taiwan Jul 5, 2024 – Taiwan Intellectual Property Office has granted ImmunAdd the patent on the preparation of triterpenoid compound. “Innovation for Better Health” We are ImmunAdd.
TAIPEI, Taiwan May 16, 2024 – ImmunAdd, a privately held company developing a fully synthetic saponin-based small molecule, attended to WVC Washington during 4/2~4/4. ImmunAdd is a group of scientists with extensive knowledge of medical chemistry, drug formulation, drug regulations, biological animal evaluation, and clinical trials, and is working on developing drugs for infectious disease, […]
- 1
- 2